Natural History and Factors Associated with Overall Survival in Stage IV ALK- Rearranged Non–Small Cell Lung Cancer Jose M. Pacheco, MD, Dexiang Gao, PhD, Derek Smith, MS, Thomas Purcell, MD, MBA, Mark Hancock, MD, Paul Bunn, MD, Tyler Robin, MD, PhD, Arthur Liu, MD, PhD, Sana Karam, MD, PhD, Laurie Gaspar, MD, Brian Kavanagh, MD, MPH, Chad Rusthoven, MD, Dara Aisner, MD, PhD, Robert Doebele, MD, PhD, D. Ross Camidge, MD, PhD Journal of Thoracic Oncology Volume 14, Issue 4, Pages 691-700 (April 2019) DOI: 10.1016/j.jtho.2018.12.014 Copyright © 2018 International Association for the Study of Lung Cancer Terms and Conditions
Figure 1 Overall survival from diagnosis of stage IV anaplastic lymphoma kinase gene rearrangement positive (ALK-positive) NSCLC. The 95% confidence interval is indicated by the shaded area. Journal of Thoracic Oncology 2019 14, 691-700DOI: (10.1016/j.jtho.2018.12.014) Copyright © 2018 International Association for the Study of Lung Cancer Terms and Conditions
Figure 2 Overall survival by period during which stage IV disease was diagnosed. Journal of Thoracic Oncology 2019 14, 691-700DOI: (10.1016/j.jtho.2018.12.014) Copyright © 2018 International Association for the Study of Lung Cancer Terms and Conditions
Figure 3 Overall survival from time of diagnosis of stage IV disease for patients with anaplastic lymphoma kinase gene rearrangement positive (ALK-positive) NSCLC compared with all patients with NSCLC diagnosed at University of Colorado Cancer Center between 2004 and November 2017. HR, hazard ratio; CI, confidence interval. Journal of Thoracic Oncology 2019 14, 691-700DOI: (10.1016/j.jtho.2018.12.014) Copyright © 2018 International Association for the Study of Lung Cancer Terms and Conditions
Supplementary Figure 1 Journal of Thoracic Oncology 2019 14, 691-700DOI: (10.1016/j.jtho.2018.12.014) Copyright © 2018 International Association for the Study of Lung Cancer Terms and Conditions
Supplementary Figure 2 Journal of Thoracic Oncology 2019 14, 691-700DOI: (10.1016/j.jtho.2018.12.014) Copyright © 2018 International Association for the Study of Lung Cancer Terms and Conditions
Supplementary Figure 3 Journal of Thoracic Oncology 2019 14, 691-700DOI: (10.1016/j.jtho.2018.12.014) Copyright © 2018 International Association for the Study of Lung Cancer Terms and Conditions